The global transdermal drug patches market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for non-invasive treatment options. The global transdermal drug patches market is segmented on the basis of type, application, and region. On the basis of type, it is classified into fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. On the basis of application it includes used for hypertension (hypertension), used for contraception (contraception), used for analgesia (analgesia), used for smoking cessation (smoking cessation) and others such as angina (angina), hormone replacement therapy (HRT) etc, whereas on the basis of region it includes North America, Latin America Europe Asia Pacific Middle East & Africa).
North America dominates this market with a share over 40%. This can be attributed to high prevalence rates in chronic diseases in this region which has led to increased demand for non-invasive treatment options like these patches. Europe follows North America with a share over 30%. Asia Pacific has been witnessing rapid growth due to increasing awareness about these products among people in developing countries like India and China which are expected to drive growth in this region during the forecast period.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the Transdermal Drug Patches market.
- The increasing number of geriatric population in developing countries is also driving the growth of the Transdermal Drug Patches market.
- Increasing awareness about transdermal drug patches among consumers, especially in developed countries, will drive the growth of this market.
- Increasing demand for transdermal drug patches from emerging markets such as China and India will also drive this market.
Industry Growth Insights published a new data on “Transdermal Drug Patches Market”. The research report is titled “Transdermal Drug Patches Market research by Types (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others, ), By Applications (Used for Hypertension, Used for Contraception, Used for Analgesia, Used for Smoking Cessation, Used for Angina, Used for Hormone Replacement, ), By Players/Companies Noven, Mylan, Novartis, Johnson & Johnson, Agile Therapeutics, Teikoku Pharma USA, Immune Pharmaceuticals, Hercon Pharmaceuticals, Pocono, DURECT Corporation, Xel Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Drug Patches Market Research Report
By Type
Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others,
By Application
Used for Hypertension, Used for Contraception, Used for Analgesia, Used for Smoking Cessation, Used for Angina, Used for Hormone Replacement,
By Companies
Noven, Mylan, Novartis, Johnson & Johnson, Agile Therapeutics, Teikoku Pharma USA, Immune Pharmaceuticals, Hercon Pharmaceuticals, Pocono, DURECT Corporation, Xel Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Drug Patches Market Report Segments:
The global Transdermal Drug Patches market is segmented on the basis of:
Types
Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Used for Hypertension, Used for Contraception, Used for Analgesia, Used for Smoking Cessation, Used for Angina, Used for Hormone Replacement,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Noven
- Mylan
- Novartis
- Johnson & Johnson
- Agile Therapeutics
- Teikoku Pharma USA
- Immune Pharmaceuticals
- Hercon Pharmaceuticals
- Pocono
- DURECT Corporation
- Xel Pharmaceuticals
Highlights of The Transdermal Drug Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
- Others
- By Application:
- Used for Hypertension
- Used for Contraception
- Used for Analgesia
- Used for Smoking Cessation
- Used for Angina
- Used for Hormone Replacement
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Drug Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transdermal drug patches are a type of medication that are placed on the skin. They work by releasing the medication into the body through the skin. This means that transdermal drug patches do not have to be taken orally (by mouth).
Some of the major companies in the transdermal drug patches market are Noven, Mylan, Novartis, Johnson & Johnson, Agile Therapeutics, Teikoku Pharma USA, Immune Pharmaceuticals, Hercon Pharmaceuticals, Pocono, DURECT Corporation, Xel Pharmaceuticals.
The transdermal drug patches market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal Drug Patches Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal Drug Patches Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal Drug Patches Market - Supply Chain
4.5. Global Transdermal Drug Patches Market Forecast
4.5.1. Transdermal Drug Patches Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal Drug Patches Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal Drug Patches Market Absolute $ Opportunity
5. Global Transdermal Drug Patches Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal Drug Patches Market Size and Volume Forecast by Type
5.3.1. Fentanyl Transdermal Patch
5.3.2. Nicotine Transdermal Patch
5.3.3. Buprenorphine Transdermal Patch
5.3.4. Clonidine Transdermal Patch
5.3.5. Oxybutynin Transdermal Patch
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal Drug Patches Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal Drug Patches Market Size and Volume Forecast by Application
6.3.1. Used for Hypertension
6.3.2. Used for Contraception
6.3.3. Used for Analgesia
6.3.4. Used for Smoking Cessation
6.3.5. Used for Angina
6.3.6. Used for Hormone Replacement
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal Drug Patches Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal Drug Patches Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal Drug Patches Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal Drug Patches Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal Drug Patches Demand Share Forecast, 2019-2026
9. North America Transdermal Drug Patches Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal Drug Patches Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal Drug Patches Market Size and Volume Forecast by Application
9.4.1. Used for Hypertension
9.4.2. Used for Contraception
9.4.3. Used for Analgesia
9.4.4. Used for Smoking Cessation
9.4.5. Used for Angina
9.4.6. Used for Hormone Replacement
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal Drug Patches Market Size and Volume Forecast by Type
9.7.1. Fentanyl Transdermal Patch
9.7.2. Nicotine Transdermal Patch
9.7.3. Buprenorphine Transdermal Patch
9.7.4. Clonidine Transdermal Patch
9.7.5. Oxybutynin Transdermal Patch
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal Drug Patches Demand Share Forecast, 2019-2026
10. Latin America Transdermal Drug Patches Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal Drug Patches Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal Drug Patches Market Size and Volume Forecast by Application
10.4.1. Used for Hypertension
10.4.2. Used for Contraception
10.4.3. Used for Analgesia
10.4.4. Used for Smoking Cessation
10.4.5. Used for Angina
10.4.6. Used for Hormone Replacement
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal Drug Patches Market Size and Volume Forecast by Type
10.7.1. Fentanyl Transdermal Patch
10.7.2. Nicotine Transdermal Patch
10.7.3. Buprenorphine Transdermal Patch
10.7.4. Clonidine Transdermal Patch
10.7.5. Oxybutynin Transdermal Patch
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal Drug Patches Demand Share Forecast, 2019-2026
11. Europe Transdermal Drug Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal Drug Patches Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal Drug Patches Market Size and Volume Forecast by Application
11.4.1. Used for Hypertension
11.4.2. Used for Contraception
11.4.3. Used for Analgesia
11.4.4. Used for Smoking Cessation
11.4.5. Used for Angina
11.4.6. Used for Hormone Replacement
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal Drug Patches Market Size and Volume Forecast by Type
11.7.1. Fentanyl Transdermal Patch
11.7.2. Nicotine Transdermal Patch
11.7.3. Buprenorphine Transdermal Patch
11.7.4. Clonidine Transdermal Patch
11.7.5. Oxybutynin Transdermal Patch
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal Drug Patches Demand Share, 2019-2026
12. Asia Pacific Transdermal Drug Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal Drug Patches Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal Drug Patches Market Size and Volume Forecast by Application
12.4.1. Used for Hypertension
12.4.2. Used for Contraception
12.4.3. Used for Analgesia
12.4.4. Used for Smoking Cessation
12.4.5. Used for Angina
12.4.6. Used for Hormone Replacement
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal Drug Patches Market Size and Volume Forecast by Type
12.7.1. Fentanyl Transdermal Patch
12.7.2. Nicotine Transdermal Patch
12.7.3. Buprenorphine Transdermal Patch
12.7.4. Clonidine Transdermal Patch
12.7.5. Oxybutynin Transdermal Patch
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal Drug Patches Demand Share, 2019-2026
13. Middle East & Africa Transdermal Drug Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal Drug Patches Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal Drug Patches Market Size and Volume Forecast by Application
13.4.1. Used for Hypertension
13.4.2. Used for Contraception
13.4.3. Used for Analgesia
13.4.4. Used for Smoking Cessation
13.4.5. Used for Angina
13.4.6. Used for Hormone Replacement
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal Drug Patches Market Size and Volume Forecast by Type
13.7.1. Fentanyl Transdermal Patch
13.7.2. Nicotine Transdermal Patch
13.7.3. Buprenorphine Transdermal Patch
13.7.4. Clonidine Transdermal Patch
13.7.5. Oxybutynin Transdermal Patch
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal Drug Patches Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal Drug Patches Market: Market Share Analysis
14.2. Transdermal Drug Patches Distributors and Customers
14.3. Transdermal Drug Patches Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Noven
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agile Therapeutics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teikoku Pharma USA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Immune Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hercon Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pocono
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. DURECT Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Xel Pharmaceuticals
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
&n
